@article{ATM22495,
author = {Roland Ehrenberg and Niels Halama},
title = {FOLFOX plus cetuximab in first-line therapy of advanced colorectal cancer},
journal = {Annals of Translational Medicine},
volume = {6},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {Oxaliplatinum is derivate of platinum, which has been used for colorectal cancer since 1997 in France for first-line therapy of metastatic colorectal cancer. Following the data from the MOSAIC trial (1), oxaliplatinum-based adjuvant therapy was established. Development of the oxaliplatinum-based protocols lead to the development of FOLFOX4 (2) and FOLFOX6 (3) and subsequent FOLFOX7 protocols (4).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/22495}
}